Remove 2010 Remove Blogging Remove Pricing Remove San Diego
article thumbnail

Murata Pays $68M for Arctic Sand, to Combine with Peregrine Semi

Xconomy

Japan’s Murata Manufacturing has acquired Arctic Sand Technologies of Burlington, MA, and plans to combine Arctic Sand’s low-power semiconductor technology with its San Diego-based subsidiary, Peregrine Semiconductor. The purchase price was $68 million, according to a Peregrine spokeswoman.

article thumbnail

Inhibrx, Fresh Off $40M Funding to Advance Cancer Drugs, Eyes IPO

Xconomy

The La Jolla, CA-based company, which is developing protein drugs targeting cancer and other diseases, was founded in 2010. Viking’s investment was a note that will convert into the company’s common stock after the initial public offering at a discount—equal to 90 percent of the price per share of the.

Funding 79
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Xconomy

In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals. million in net revenue last year, its highest sales mark since becoming a public company in 2010, according to its annual report. Consequently, Pernix’s stock price has suffered. Those acquisitions helped Pernix reach $175.8

Sales 40
article thumbnail

This Week in VC with Farb Nivi, Founder of Grockit

Both Sides of the Table

Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego. I don’t do advertising on my blog, but I thought it was worth mentioning Ryan in particular because he has an alternate model for doing a startup. They sponsor TWiVC. MetaMarkets.

article thumbnail

With Biogen at a Crossroads, CEO Scangos to Step Down

Xconomy

After a year in which Biogen’s share price has fallen by more than a third and one of its top drug prospects failed, Scangos, who has led the company since 2010, has announced plans to step down. Scangos, the former head of Exelixis (NASDAQ: EXEL ), was named Biogen’s CEO in 2010 during a rocky time.

article thumbnail

Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA

Xconomy

The small populations of patients with those diseases, combined with a lack of alternative treatments, means the drugs typically command very high prices—on average, an estimated $111,820 per patient, per year between 2010 and 2014, according to the report. The first-ever treatment for SMA could soon gain approval, too.

article thumbnail

63 Los Angeles Entrepreneurs To Be Proud Of

SoCal Delicious

Charlie Capen is co-founder of HowToBeADad.com , an entertainment site and dad blog for “parents, soon-to-be parents and people who have no desire to procreate, whatsoever.” Heather McPhaul is the founder of AgingGal.com , a funny little blog about aging and other inconveniences. Charlie Capen – Co-founder of HowToBeADad.com.